RE:RE:GOOD READ! The following title for this study represents even more support for the game changing potential of AcuVid, particularly for the niche it could occupy ...which is expansive.
https://www.nature.com/articles/s41598-021-82787-z
"Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection"
Smokey1958 wrote:
To add to the reading list, thanks Freedom! This study was carried out in January of 2021 and published in the The American Journal of Cardiology. I will include the link for the study that reviewed previous analysis of over 7000 samples.
Their conclusion ....
Sample collection through saliva or nasopharyngeal swabbing does not differ significantly in sensitivity. Salivary collection, however, is much less costly.
https://www.acc.org/latest-in-cardiology/journal-scans/2021/01/18/22/48/the-sensitivity-and-costs-of-testing
FREEDOM55 wrote: https://www.the-scientist.com/news-opinion/covid-19-diagnostics-how-do-saliva-tests-compare-to-swabs--68035